127 related articles for article (PubMed ID: 10744076)
1. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
[TBL] [Abstract][Full Text] [Related]
2. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
[TBL] [Abstract][Full Text] [Related]
4. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
[TBL] [Abstract][Full Text] [Related]
8. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
9. Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique.
Tan D; Wiseman S; Zhou Y; Li Q; Ward P; Slocum HK; Alrawi S; Loree T; Hicks W; Rigual N; Anderson G; Stoler D
Diagn Mol Pathol; 2004 Mar; 13(1):33-40. PubMed ID: 15163007
[TBL] [Abstract][Full Text] [Related]
10. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
McEvoy CR; Seshadri R; Morley AA; Firgaira FA
Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
[TBL] [Abstract][Full Text] [Related]
11. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
13. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
14. Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.
Beder LB; Gunduz M; Ouchida M; Gunduz E; Sakai A; Fukushima K; Nagatsuka H; Ito S; Honjo N; Nishizaki K; Shimizu K
J Cancer Res Clin Oncol; 2006 Jan; 132(1):19-27. PubMed ID: 16170569
[TBL] [Abstract][Full Text] [Related]
15. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
16. Frequent HLA class I loss is an early event in cervical carcinogenesis.
Vermeulen CF; Jordanova ES; Zomerdijk-Nooijen YA; ter Haar NT; Peters AA; Fleuren GJ
Hum Immunol; 2005 Nov; 66(11):1167-73. PubMed ID: 16571417
[TBL] [Abstract][Full Text] [Related]
17. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
18. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.
Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE
Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046
[TBL] [Abstract][Full Text] [Related]
19. High resolution mapping of chromosome 6 deletions in cervical cancer.
Mazurenko N; Attaleb M; Gritsko T; Semjonova L; Pavlova L; Sakharova O; Kisseljov F
Oncol Rep; 1999; 6(4):859-63. PubMed ID: 10373671
[TBL] [Abstract][Full Text] [Related]
20. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
